Wheelchair Market is Growing at a Healthy CAGR of 2.5% During 2019-2024

Market Analysis:

A wheelchair is basically a chair having wheels that is used when people face difficulty to walk or walking is impossible due to disability, injury, or illness. It is available in different types such as robotic, power, manual, electric, and others to cater to the user’s specific needs. Of these, robotic wheelchairs and power wheelchairs are in great demand, and the key factors adding to the robotic wheelchairs market growth and power wheelchair market growth include increasing aging population, increasing use of automation in healthcare, rising prevalence of multiple sclerosis, and huge healthcare expenditure. 

The global Wheelchair Market Trends is likely to touch USD 9,554.07 million at a 2.80% CAGR between 2019-2024, as per the latest Market Research Future (MRFR) report.

Numerous factors are adding to the global wheelchair market. Such factors, according to the MRFR report, include increasing obesity rate, an increase in spinal cord injuries, growing elderly population, improvement in healthcare facilities, rising handicapped population, rising prevalence of chronic disorders, advances in wheelchair technology, and favorable reimbursement scenario. 

On the contrary, the high price of electric wheelchairs may limit the global wheelchair market growth. 

Key Players:

Leading players profiled in the global wheelchair market report include Invacare Corporation (US), Medline Industries, Inc. (US), Sunrise Medical (Germany), Levo AG (Switzerland), Pride Mobility Products Corp. (US), Karman Healthcare, Inc. (US), GF Health Products, Inc. (US), Quantum Rehab (US), Ottobock (Germany), and Drive Medical (US). Top wheelchair manufacturers have adopted several strategies to create a footprint in the market, such as collaborations, new product launches, and alliances. 

Market Segmentation :

·         The MRFR wheelchair market research report provides an inclusive segmental analysis of the global wheelchair market based on end user and product type. 

·         By product type, the wheelchair market is segmented into the manual wheelchair, electric wheelchair, and accessories. The electric wheelchair is again segmented into front-wheel drive chair, center wheel drive chair, and rear-wheel drive chair. The manual wheelchair is again segmented into sport wheelchairs, bariatric wheelchairs, light & ultra-lightweight wheelchairs, and standard manual wheelchairs. Accessories are again segmented into batteries and chargers, wheelchair trays, armrest accessories, postural support accessories, and wheelchair ramps. Of these, the electric wheelchair will dominate the market over the forecast period. 

·         By end user, the wheelchair market is segmented into hospitals & clinics and home care settings. Of these, home care settings will lead the market during the forecast period. 

Regional Analysis:

By region, the global wheelchair market report covers the recent trends and growth opportunities across the Americas, Europe, the Asia Pacific (APAC), and the Middle East and Africa (MEA). Of these, the Americas will have the lions share in the market during the forecast period for the increasing geriatric population, rising incidence of chronic diseases, and the presence of leading market players. 

The global wheelchair market in Europe is predicted to hold the second-largest share during the forecast period for the increasing use of a wheelchair and growing elderly population. It is predicted to touch USD 247.2 million by 2050. 

The global wheelchair market in the APAC region is predicted to grow at the fastest pace over the forecast period for the increasing number of hospitals and the huge geriatric population. 

The global wheelchair market in the MEA will have a small share during the forecast period for limited access to as well as the accessibility of treatment facilities. 

Industry News:

March 2020: Israeli robotic standing wheelchair UPnRIDE robotics has received FDA clearance for US sales. This wheelchair will allow quadriplegics to moving around outdoor and indoor environments while standing upright. It is ideal for use for people having ALS, multiple sclerosis, the elderly, paraplegics, quadriplegics, and other conditions that limit mobility. 

Prefilled Syringes Market is Growing at a Healthy CAGR of 10.20% During Forecast 2019-2024

Market Overview:
Prefilled syringes are defined as disposable syringes (meant for one-time use) that are alreadyfilled with the pharmaceutical substances that are to be injected into the patient’s body. A new report on the global prefilled syringes market, published by Market Research Future (MRFR),points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms ofmoney value, the market can be worth USD 8397.23 Mn by the end of the forecast period.
A new report on the global Prefilled Syringes Market Trends published by Market Research Future (MRFR), points out that this market could see a rise at 10.20% CAGR between 2016 and 2024. In terms of money value, the market can be worth USD 8397.23 Mn by the end of the forecast period.

Key Players:

• Abbott
• Baxter International
• Becton Dickinson & Company
• Gerresheimer AG
• Medtronic
• Nipro Corporation
• OMPI
• Schott AG
• Terumo Corporation
• Vetter Pharma International GmbH
• Weigao Group
• West Pharmaceutical

Market Segmentation:

• The global prefilled syringes market segmentation encompasses design, end-user, material, and type. MRFR’s take on the market surveys various facets of the market in-depth.
• The design-based segmentation of this market covers single-chamber prefilled syringes, dual-chamber prefilled syringes, and customized prefilled syringes. During the forecast period, the dual-chamber prefilled syringes segment is expected to grow at 10.31% CAGR. Single-chamber prefilled syringes segment is expected to hold the larger market share of 56% in the global market.
• Regarding end-users, the market has been segmented into the ambulatory surgical center and hospitals/clinics. Due to the growing number of public hospitals as well as private hospitals, the hospitals segment has been anticipated to grow faster during the forecast period.
• Based on material, the market has been segmented into glass prefilled syringes and plastic syringes. The glass prefilled syringes segment has been sub-segmented into baked on silicone syringes and oil siliconized syringes. Plastic syringes segment has higher growth due to its usage in many applications of pharmaceutical packaging during the forecast period.
• By type, the market has been segmented into conventional prefilled syringes and safety prefilled syringes. Conventional prefilled syringes held the larger market share of about 68% in 2017.

Regional Segmentation:
The regional analysis of the prefilled syringes market globally consists of regions is divided into Europe, Americas, Asia Pacific, Middle East and Africa.
The European region is responsible for the leading market share of about 41.4 percent in the year 2017 and is expected to lead the prefilled syringes market globally. The higher share is majorly attributed to the rising geriatric population, demand for quality healthcare and growing trend of home-based treatment separate with high healthcare expenditure.
The Americas region is responsible for the second biggest market portion, whereas the Asia Pacific region is anticipated to develop at a rapid expansion rate of about 10.78 percent during the forecast period. With loads of prospects and unceasingly developing economies, the region is expected to be among the rapidly growing area. Moreover, factors such as Japan’s quick adoption of plastic devices along with the modern healthcare developments, and increasing number of private and public hospitals, are promoting the growth of the market.
The Middle East and Africa region with a lesser degree of economic developments and very low-income per capita is responsible for the minimum market share in 2017 but is likely to develop in the future.

Latest Industry News

• Made by Regeneron, chemistry, manufacturing, and controls prior-approval supplement for the Eylea injection prefilled syringe that has been approved by the USFDA. 13 AUG 2019

Laboratory Information Systems Market is Growing Fruitfully at a Healthy CAGR of 7.1% During Forecast 2019-2025

Market Overview:

Laboratory information systems assist in ensuring effective tracking and management of security, data quality, patient demographics, end user billing, and security. The systems also allow enhanced research information integration and data sampling. Thus, the demand is high in bio-sampling applications, which drives the market across the globe. Surging investments in R&D by biotechnological and pharma organizations are offering a significant push to the overall market. Emphasis on enhancing efficiency of laboratories is predicted to help the LIS market gain momentum in the next few years. Rising trend of

laboratory automation is further estimated to offer the market a thrust.

Some of the advantages of laboratory information systems includes tracking of samples in real time, saving time through streamlined sample tracking model, focus on critical reports, efficient management of logistics, eliminating human errors, increasing of revenue and elimination of unnecessary spending. The Laboratory Information System Market will be expanding as the lab comes to play a critical role in saving human lives.

Competitive Landscape:

·         Eclipsys Corporation

·         Cerner Corporation

·         LabVantage Solutions Inc

·         McKesson Corporation

·         LabWare Inc

·         Medical Information Technology Inc

·         STARLIMS Corporation

·         Merge Healthcare Inc

·         Sunquest Corporation

·         Thermo Fisher Scientific Inc.

Segmentation:

·         Application, components, and delivery are the three segments along which the global laboratory information systems market has been subdivided.

·         Application-wise, LIS market is segmented as clinical, drug discovery, and industrial.

·         By component LIS market is divided into hardware, software and services.

·         Delivery segmentation of LIS market includes cloud-based and on-premise based.

Regional Analysis:

Geographically, the LIS market is subdivided into the Americas, Europe, Asia Pacific, and the Middle East & Africa.

North America LIS market is expected to hold a dominating position due to the adoption of cloud computing and increasing demand for lowering cost for customized healthcare services in the U.S. Health Insurance Portability and Accountability Act dictates that U.S. healthcare industry has to start adopting electronic medical records so as to efficiently and securely share data with other healthcare providers and government agencies. As a result, cloud-based LIS are expected to be more widely adopted and enable laboratories to share real-time information. Due to increased expenditure on healthcare and enhanced healthcare infrastructure in North America and Western Europe, LIS market is expected to expand in these regions over the coming years.

Increasing adoption of new technologies, patient awareness and rising rate of disease incidence would help to augment LIS market growth in Europe. Rising demand for integrated healthcare systems and a market ripe for enhanced healthcare facilities would drive LIS market in the region.

Asia and Latin America LIS market are expected to witness fast paced growth due to increasing incidences of diseases, government initiatives for enhancement of healthcare infrastructure and rising investments from healthcare IT players. Due to the presence of emerging economies in the regions and expanding expenditure in healthcare services, many international LIS firms have shown increased interest in these regions thus raising the potential of LIS market expansion in the regions.

Appendicitis Market is Gaining Extensively at a Healthy CAGR of 4.06% During Forecast 2019-2024

Appendicitis Market – Overview:

The global appendicitis market is growing pervasively mainly due to the availability of many novel treatment and diagnostic procedures. The provision of more critical care services and the addition of super specialty departments and beds have led to an increase in the major and minor surgeries. Moreover, many ongoing researches to discover novel medicines and therapeutics to treat appendicitis have achieved significant progress. These successful discoveries simultaneously, escalate the market on the global platform.

Acknowledging the exponential growth records, the market is posting continually, Market Research Future (MRFR), in its recently published analysis report asserts that the global Appendicitis Market Values will witness significant accruals by 2023 registering 4.06% CAGR throughout the forecast period (2019 – 2024). The improving economic conditions worldwide, define the growth that the appendicitis market perceives today, enabling access to the quality of life & to the improved healthcare.

Technological advancement transpired into medical science is a key driving force pushing up the growth of the market bringing about advanced diagnostic and treatment procedures. Moreover, the increasing emphasis on early diagnosis of the disease defines the market landscape.  Furthermore, the increasing occurrences of appendicitis along with the rising demand for diagnostic and treatment options of appendicitis support the market growth.

Also, factors such as the rapidly spreading awareness towards the disorder of appendicitis and the availability of its treatments foster the growth of the market across the globe.  Other factors contributing to the market growth include increasing population, rapid urbanization, and substantial investments in the R&D activities. 

On the flip side, factors such as the unmet medical needs and drug resistance restrict market growth, up to some extent. Nevertheless, technological advancements expected to take place soon are expected to support market growth throughout the forecast period, advancing medical devices.

Major Players:

·         General Electric Company

·         Siemens

·         Toshiba Medical Systems Corporation

·         Johnson & Johnson Services Inc

·         Koninklijke Philips N.V.

·         Pfizer

·         Shionogi & Co., Ltd. (Japan) among others.

·          

Global Appendicitis Market – Segmentations:

The MRFR analysis is segmented into five key dynamics for enhanced understanding.

By Type             : Acute, And Chronic Appendicitis

By Diagnosis    : Physical Examination, White Blood Cell Count, Urinalysis, and Imaging Test among others.

By Treatment  : Antibiotics and Appendectomy among others

By End-use       : Hospitals & Clinics, Diagnostic Centers, and others

By Regions                   : North America, Asia Pacific, Europe, and the Rest-of-the-World.

Appendicitis Market - Regional Analysis:

The North American region, heading with the rising prevalence of acute appendicitis accounts for the leading market for appendicitis treatment.  Factors such as the Presence of major medical device manufacturers, pharmaceutical companies, and well-developed healthcare industry positively impacts the growth of the regional market.

Technological advancements in the burgeoning healthcare industry are providing new effective drugs for treatments that can give better outcomes, and this is one of the key factors driving the growth of the regional market. Furthermore, the rising awareness about appendicitis and the availability of its treatment, and availability of emergency diagnostic services foster the market growth in the region.

The appendicitis market in the European region holds the next largest share in the global market, owing to the resurging economy that is availing the best possible healthcare and increasing the healthcare expenditures. Germany, France, and the U.K backed by the increasing demand for the technological advanced diagnostic devices account for the major contributors to the Europe appendicitis market.

The well-developed healthcare sector and the notable pharmaceutical companies that are engaged in R&D activities for the development of new drugs to treat appendicitis are some of the key driving forces behind the growth of the regional market. Additionally, government support is fostering the market growth in the region, encouraging the market players to develop effective therapeutics.

Whereas, the Asia Pacific appendicitis market is growing rapidly, emerging as a promising market, globally owing to the introduction of new & advanced diagnostic options such as CT scan. The rising demand for specialty healthcare services in emerging countries such as India has fuelled the growth of the regional market.

Also, factors such as the ever-increasing population and the integration of advanced technologies in the healthcare sector are propelling the growth of the regional market. Asian countries especially, India and China provide immense growth opportunities for the appendicitis market, accounting for the considerable investment in R&D activities for prognostic treatments and drug formulation.

Industry/Innovation/ Related News:

January 15, 2019 --- A group of scientists from the different universities of Izmir, Turkey including Department of Pediatric Surgery, Izmir Katip Celebi University, and Department of Microbiology, Ataturk Education & Research Hospital, Turkey, published their study on Pentraxin-3, a strong novel biochemical marker for appendicitis in children in the American Journal of Emergency Medicine. 

Researchers investigated the diagnostic values of pentraxin-3/PTX-3 in pediatric appendicitis and compared it with the other serum parameters.

In this study, these researchers have shown that PTX-3 is very useful with high specificity and sensitivity in the diagnosis of appendicitis compared to ANS, WBC, NLR, and CRP as a first in the literature.

Lung Cancer Treatment Market is Growing Extensively at a Healthy CAGR of 13.5% During Forecast 2018-2023

Market Overview:

Lung cancer is the second most common type of cancer in both men and women, with about 13% of all new cancers projected to be cases of lung cancer. According to the American Cancer Society, the incidence of lung cancer is quite high in the U.S., resulting in more than 142,000 deaths in 2019. The global lung cancer market has been driven by the growing body of cancer research and the rapid growth in the prevalence of lung cancer, which has driven political will to fund cancer research. The rising government support to lung cancer research, as well as rising private investment in the sector, is likely to be a major driver for the global lung cancer market over the forecast period.

Market Research Future (MRFR) has announced a new release on the global Lung Cancer Therapeutics Market projecting the market to reach a valuation of close to USD 37 billion by 2023, rising from a 2016 valuation of USD 15.2 billion at a CAGR of 13.5% over the forecast period from 201 to 2024.

The market features a solid research arm, with several major players involved in a number of research efforts in order to make lung cancer diagnosis smoother and better, and lung cancer treatment more effective.

Additionally, smoking, environmental pollution, and rising cases of infections foster the market, increasing the prevalence of the condition.  Moreover, rapidly spreading awareness towards novel treatments available for lung cancer and reimbursements procedures & expanding health insurance are some of the significant growth propellers.

Conversely, inadequate expertise that brings down the cure rates and increases side effects & failure rates of lung transplant surgeries are the major factors impeding the growth of the market. Also, retrieval nature and faster growth of lung cancer that leads to reduced life expectancy, endangering the life of patients restrict the market growth.

Competitive Analysis:

·         F. Hoffman-La Roche

·         Pfizer Inc.

·         Bristol-Myers Squibb Company

·         Sanofi

·         Eli Lilly and Company

·         Merck & Co

·         Novartis

Segmentation:

·         Global lung cancer market has been segmented on the basis of type into small cell lung cancer and non-small cell lung cancer. NSCLC more common than small cell lung cancer and has higher prevalence figures.

·         On the basis of treatment, the lung cancer market is segmented into surgery, chemotherapy, radiotherapy, photodynamic therapy (PDT), and laser therapy.

·         By end use, the market comprises hospitals & clinics, cancer research centers, and laboratories.

Regional Analysis:

North America leads the global lung cancer market with the increasing government support for research & development. The presence of the well-developed healthcare sector and a huge patient population, alongside, the high healthcare spending foster the growth of the market. The lung cancer market in the US, heading with the increasing healthcare spending accounts for the major growth contributor to the regional market.

The lung cancer market in the European region accounts for the second-largest market, globally. Increasing healthcare spending and well-developed healthcare sector drive the growth of the lung cancer market in the region. Rising government support for R&D activities in biologics and biotechnology are substantiating the growth of the market in the region.

The Asia Pacific lung cancer market is increasing owing to the significant advancements in the field of biotechnology and the increasing government support for the R&D activities required for the discoveries of breakthrough treatment and medicines for lung cancer. Additionally, rising healthcare expenditure and rapidly increasing awareness about the availability of the treatment are some of the factors driving the growth in the regional market.

Medical Devices and Accessories Market is Growing at a Healthy CAGR During Forecast to 2023

Market Insights:

Medical devices and accessories refer to any apparatus, machine, instrument used for the treatment of disease and illness through monitoring, diagnosis, and treatment. Growing occurrences of chronic diseases and diabetes, geriatric population, rising cases of surgical cases, healthcare expenditure, and technological advancements for superior medical infrastructures, and constant investments by industry giants are some of the pointers that might help the global medical device and accessories market to flourish during the forecast period.

Market Research Future stated that the global Medical Devices and Accessories Market is estimated to register a CAGR of 6.53%, reaching the valuation of USD 133,835.9, during the forecast period, 2014-2023.

Other additional factors influencing the growth of the global market include mergers and collaboration led by the market players.

Major Players:

• Koninklijke Philips n.v
• General Electric Company
• Medtronic
• Johnson & johnson Services
• Siemens AG
• Danaher Corporation
• Stryker Corporation
• Boston Scientific Corporation

Market Segmentation:
The medical devices and accessories market is diversified by various types of devices.
On the basis of devices, the market study is divided into the therapeutic medical guide, dental implant, coronary pressure, monitors, cochlear implant, nerve stimulator, diabetes monitors market, global suture needles, cardiovascular application, and catheters.
The cardiovascular segment is further sub-segmented to cardiac pacemakers, cardiac defibrillators, cardiac monitors, and others. The coronary pressure monitor is sub-segmented into instruments, pressure monitor, BP transducers, and automated blood ambulatory blood pressure monitor, sphygmomanometer. The catheter segment is classified into neurological catheters, cardiovascular catheters, specialty catheters, urinary catheters, and intravenous catheters. The therapeutic medical guidewire segment bifurcated into solid guidewire and wrapped guidewire. The nerve stimulator segment is divided into deep brain stimulators, vagus nerve stimulators, and spinal cord stimulators.

Regional Outlooks:
The strong health trend associated with rising health care spending in North America should strengthen the regional medical device and accessory market. Technological progress in supporting medical infrastructure is increasingly attracting investment from influential market players in research and development, paving the way for new and innovative products. These factors have a powerful positive effect on the US market. North America is set to lead the global medical devices and accessories market.

The European region is expected to be second in the world market due to high medical costs, government support, and exceptional medical infrastructure.

The Asia Pacific region is likely to see the fastest-growing market. The growing geriatric population and the technological progress that creates opportunities for innovation are key factors in the regional market that may stimulate the Asia Pacific medical device market in the near future.

The growth of the medical device and equipment market in the Middle East and the African region, due to the lower availability of medical facilities and socioeconomic decline, is considered the smallest in the market in the coming years.

Recent Updates
The Indian government is emphasizing to place a proposal for American companies to manufacture medical devices in India to mitigate the issue of high cost. The medical device imports jumped in India to Rs 38,837 crore, rising to 24% in FY 2019. The US is the largest medical device exporter to India, acquiring a one-fifth share of the market in India, followed by other exporters such as Germany, China, Singapore, and the Netherlands.

Companion Diagnostic Market is Growing Dynamically at a Healthy CAGR of 15.4% During Forecast 2018-2023

Market Scope:

Companion diagnostics (CDx) are assaysor medical devices which provides information on the safe consumption or use of a drug or biological product. The test can determine the compatibility of the drug with the patient. Personalized medicine has pushed such devices to the forefront with many patients opting for this safe service to nullify side-effects of any drugs. Market Research Future (MRFR) asserts in its latest companion diagnostic market report the various developments and trends which can take place during the period of 2018 to 2023 (forecast period).

The global Companion Diagnostic Market Size is set to touch a valuation of USD 12,647.5 million by 2023. It is pegged to display a CAGR of 15.4% over the forecast period. High costs of drug discovery and drug development is the primary factor driving market growth. CDx devices can provide vital information on the safety of drugs with respect to the individual. The use of these devices by pharmaceutical companies for improving the clinical outcomes of new drugs can positively impact the market.

Improving the validity and accuracy of biomarkers for identifying cancerous cells can also fuel market growth. The adoption of personalized medicine and chances of improving patient outcomes that can lower healthcare costs and minimize drug use can have a positive impact on the global companion diagnostic market.

However, the concerns over inaccuracy of test results may impede the market growth.

Competition Outlook:

F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Qiagen N.V., Agilent Technologies, ARUP Laboratories, Abbott Laboratories, and Myriad Genetics, Inc.

Segmentation:

·         The global companion diagnostics marketreport is segmented by technology, application, and end user.

·         By technology, it has been segmented into polymerase chain reaction (PCR), in-situ hybridization, and immunohistochemistry. In-situ hybridization is a method in which modified DNA or RNA strands are used to localize a particular group of DNA or RNA in a section of the tissue. It can reveal the location of specific chromosomes, which can be used to target specific group of cells without affecting the neighboring cells. Immunohistochemistry is an examination for identification of carcinomas of unknown primary site (CUP). It can be used in identification and classification of cancerous cells in the body.

·         Applications in the companion diagnostics market comprise as central nervous system disorders, cancer, infectious diseases, cardiovascular diseases, and others.  Cancer is a disease which is accountable for many deaths annually. Companion diagnostics falls under pharmacogenomics which uses the genetic makeup of an individual for creating drugs suited for that individual. The success of personalized medicine using CDx assays as a base for identification of such traits can bode well for the market. Neurological disorders have a genetic disposition and scientists are redoubling their efforts at creating effective biomarkers for treating disorders such as Alzheimer’s.

·         By end user, the companion diagnostics market caters to clinical laboratories, contract research organizations, pharma & biotech companies, and others.

Regional Analysis:

The global companion diagnostics market, based on region, is divided into the Americas, Europe, AsiaPacific (APAC), and the Middle East & Africa (MEA).

The Americas can continue to dominate the global companion diagnostics market. Within the region, North America can lead mainly due to an established healthcare system and technological advancement in drugs. Presence of large number of players has led to collaborations and partnerships between pharmaceutical companies and firms specializing in companion diagnostics.

Europe has assumed the second-largest position in the market. Focus on improving imaging and assays for chronic diseases as well as focus on targeted therapies for oncology can induce demand in the global companion diagnostic market. Germany and the U.K. are expected to be the biggest revenue generators of the region.

Actinic Keratosis Treatment Market is growing Physically at a Healthy CAGR of 4.20% During Forecast 2019-2024

Market Analysis: 
Actinic keratosis, simply put, is a scaly, rough patch on the skin which results from years of sun exposure. It is commonly found on the neck, scalp, forearms, back of the hands, ears, lips, or face. The size varies from a small inch to about a diameter, and when left untreated, such areas of the skin can turn into a serious type of skin cancer. Change in the color of the skin (brown, flesh-colored, or pink), hard wart-like surface, burning sensation and itching, and rough, patchy, scaly skin are some of its common symptoms.

The global Actinic Keratosis Treatment Market Key Players predicted to touch USD 6,088.4 million at a 4.20% CAGR over the forecast period (2015-2024), states the new Market Research Future (MRFR) report. No two cases will appear the same, yet is likely to share similar features such as sandpaper texture, crusty patches, raised patches, and red scales. Though anyone can develop actinic keratosis, but those with fair skin, particularly blonde or red hair, green or blue eyes, or skin that easily burns or freckles have a higher risk of experiencing actinic keratosis.

Various factors are propelling the actinic keratosis treatment market growth. These factors, according to the new MRFR report, include its increasing prevalence, increasing acceptance of therapeutic procedures that are minimally invasive, growing geriatric population, and the presence of suitable medical coverage. Additional factors pushing market growth include the availability of suitable medical attention and environmental factors such as excessive sun exposure and ozone depletion.

On the flip side, high cost of treatment, risk factors related to the available treatment, low penetration of actinic keratosis treatment market especially in developing economies, and scarcity of skilled medical professionals are factors that may impede the actinic keratosis treatment market growth over the forecast period.

Key Players:

• Cipher Pharmaceuticals Inc.
• Valeant Pharmaceuticals
• Sun Pharmaceutical Industries Ltd
• Alma Lasers
• Stanford Chemicals
• 3M
• Leo Pharma
• BioLineRx
• Biofrontera AG

Market Segmentation:

• The MRFR report provides a complete segmental analysis of the actinic keratosis treatment market report on the basis of end user, procedure, and medication. 

• Based on medication, the actinic keratosis treatment market is segmented into diclofenac gel, ingenol mebutate gel, imiquimod cream, fluorouracil cream, and others. 

• Based on procedure, the actinic keratosis treatment market is segmented into chemical peels, laser, photodynamic therapy, cryotherapy, and others. Of these, the cryotherapy segment will have the largest share in the market over the forecast period. This is a common treatment used for actinic keratosis. 

• Based on end user, the actinic keratosis treatment is segmented into ambulatory surgical centers, dermatology clinics, and hospitals and oncology centers. Of these, the hospitals and oncology segment will dominate the market over the forecast period. 

Regional Analysis:
By region, the actinic keratosis treatment market report covers the latest trends and growth opportunities across the Asia Pacific, Europe, the Americas, and the Middle East and Africa. Of these, the Americas will spearhead the market over the forecast period. Factors aiding growth in the region include easy availability of advanced treatment methods such as monotherapy and combination therapy and increasing efforts taken on cancer research in the region.

The actinic keratosis treatment market in the APAC region is predicted to have significant growth over the forecast period. Factors aiding growth in the region include growing government support for medical tourism, rising healthcare spending, rising literacy rates, rapidly growing healthcare infrastructure, and rising disposable income. India, Japan, and China are the key contributors in this region.

The actinic keratosis treatment market in Europe will have a favorable growth over the forecast period while the Middle East and Africa will experience sluggish growth.